Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Q2 Revenues Increased, But Under $1M

NEW YORK, July 23 - Large Scale Biology reported revenues of $0.9 million for the second quarter, compared to $490,000 in the same period last year.


The Vacaville, Calif., company had a net loss of $6.2 million for the quarter, compared to $9.6 million for the second quarter of 2002.


LSBC's R&D expenses narrowed to $2.8 million, from $5.9 million in the year-ago quarter. These expense reductions follow a restructuring program announced in June, in which the company plans to cut costs $5 million within the year. 


At the end of the second quarter, the company had $15.0 million in cash and marketable securities.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.